Lung Cancer Patient Education
A Breath of Hope hosts the Animated Patient’s Guide to Lung Cancer to educate all lung cancer patients, regardless of their level of education or learning style, toward our shared goal of improved health outcomes. With this knowledge, patients can better participate in decisions about their care (shared decision-making) which has been shown to improve outcomes.
Thanks to our Pharma funding partners and our patient literacy expert partner, Mechanisms in Medicine (MIM), we were able to develop and implement this interactive, highly visual, evidence-based e-learning web resource for lung cancer patients and their families in 2017 and we continue to build on its success. As of 2022, the program had already drawn nearly 500,000 visits from 35 countries.
The Animated Patient’s Guide to Lung Cancer is unique because it delivers information in easy-to-digest segments for different learning styles. For some, auditory input is most valuable; others rely upon a visual style. Whether the user of this product is a college graduate or a ninth-grade student, this learning resource will lead to a better understanding of lung cancer.
Patients with lung cancer have innumerable unmet needs and care gaps. A Breath of Hope’s goal is to educate, inform, ease the burden of disease, provide practical decision tools, and support patients and their caregivers during the journey.
LEARN MORE ABOUT YOUR LUNG CANCER DIAGNOSIS:
- Understanding Non-Small Cell Lung Cancer (NSCLC)
- Understanding Small Cell Lung Cancer (SCLC)
- Diagnosis and Staging of Lung Cancer
- Treatment and Management of Lung CancerImmunotherapy for Lung Cancer
- Understanding Biomarker Testing in Non-Small Cell Lung Cancer
- Target Therapy in Non-Small Cell Lung Cancer
We are also pleased to offer you an Animated Patient’s Guide to Lung Cancer in Español
EXPERT VIDEOS
Understanding Non-Small Cell Lung Cancer; Presented by Pasi Janne, MD, PhD, Scientific Professor, Farber Cancer Institute:
- What is non-small cell lung cancer?
- What are the risk factors for non-small cell lung cancer?
- What are the symptoms of non-small cell lung cancer?
- What are my options for treatment and management of non-small cell lung cancer?
Understanding Small Cell Lung Cancer; Presented by Pasi Janne, MD, PhD, Scientific Professor, Farber Cancer Institute:
- What is small cell lung cancer?
- What are the risk factors for small cell lung cancer?
- What are the symptoms of small cell lung cancer?
- What are my options for treatment and management of small cell lung cancer?
Diagnosis and Staging of Lung Cancer; Presented by Pasi Janne, MD, PhD, Scientific Professor, Farber Cancer Institute and Shandra Blackmon, MD, MPH, Associate Professor, Mayo Clinic:
- How is non-small cell lung cancer diagnosed?
- How is small cell lung cancer diagnosed?
- What is ‘screening’ for lung cancer?
- What is ‘staging’ for lung cancer and how is it determined?
- What is stage I, II, III, or IV lung cancer?
- If someone with lung cancer has poor lung function, what should they be aware of?
- What does it mean if a patient has ‘metastatic lung cancer’?
- What is ‘multi-focal lung cancer’?
- What is ‘bronchoscopic ablation’?
- What kind of healthcare team is a lung cancer patient likely to see?
- What does ‘pulmonary lung function’ mean and how is it tested?
- What is a ‘lung biopsy’?
Treatment and Management of Lung Cancer; Presented by Pasi Janne, MD, PhD, Scientific Professor, Farber Cancer Institute and Shandra Blackmon, MD, MPH, Associate Professor, Mayo Clinic:
- What kind of surgery is used for non-small cell lung cancer?
- What factors determine the extent of lung cancer surgery?
- Is surgery and option for small cell lung cancer?
- What is ‘chemotherapy’? When is it needed?
- What is ‘radiation therapy’? When is it needed?
- What is ‘targeted therapy’? When is it needed?
- What is ‘immune therapy’? When is it needed?
- What is ‘genomic testing’? Why is it needed?
- What is a ‘clinical trial’?
- Is a ‘placebo’ always used in a controlled clinical trial?
- When would a patient with lung cancer consider ‘palliative care’?
- What should a patient think when their doctor says “We do not want to do surgery”?
- What is a ‘lobectomy’?
- What is a ‘lung ablation’?
- Can you have lung ablation after radiation therapy?
- What is ‘percutaneous ablation’?
- What is a ‘wedge surgery’?
- What are ‘lung sparing techniques’?
- What is a ‘segmentectomy’?
- What is an ‘EGFR’ mutation for lung cancer?
Biomarker Testing and Targeted Therapy in Non-Small Cell Lung Cancer; Presented by Robert Winn, MD, Director, VCW Massey Cancer Center:
- What is ‘comprehensive biomaker testing’ and why is it important in lung cancer?
- What is a ‘driver mutation’?
- How is biomarker testing carried out?
- When should biomaker testing be done in non-small cell lung cancer?
- Which biomakers exist for non-small cell lung cancer?
- What happens if my tumor test positive for a biomarker? What happens if it doesn’t test positive?
- What if I have already had a biopsy and my tumor was not tested for a biomarker?
- What should a newly diagnosed lung cancer patient do it biomarker testing is not offered to them?
- Why is biomarker testing so important for certain ethnic groups, such as African Americans?
- How can we close the gaps to make sure all non-small cell lung cancer patients get tested?
- What is targeted therapy for lung cancer?
- What targeted therapies are used for people with EGFR mutation?
- What targeted therapies are used for people with ALK mutation?
- What targeted therapies are used for people with ROS1 mutation?
- What is the importance of combination therapies for BRAF?
- What is the future of combination therapy for lung cancer?
- Can biomarker testing help identify clinical trial opportunities for me?
- How can communities of color increase their participation in clinical trials?
Here is an excerpt of one of the videos you can find in the animated program: